Skip to main content

Locus Pharmaceuticals Taps into IBM s Computing on Demand

NEW YORK, Dec. 2 (GenomeWeb News) - Locus Pharmaceuticals will use supercomputing power from IBM's Deep Computing Capacity on Demand center to support its drug discovery and development activities, IBM said today.

Locus will augment its existing 2.3 teraflop supercomputing infrastructure by tapping into an IBM eServer Linux cluster system located at IBM's on-demand center in Poughkeepsie, New York.

Jeff Wiseman, vice president of technology and informatics at Locus Pharmaceuticals, said that IBM's computer scientists worked with the company to optimize its proprietary drug-design algorithms for the on-demand computing environment.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.